Your browser doesn't support javascript.
loading
Evaluation of Long-Coronavirus Disease 2019 Cases Readmitted to Intensive Care Units Due to Acute Respiratory Failure: Point Prevalence Study.
Tunçay, Eylem; Moçin, Özlem; Edibogdu, Özlem; Adigüzel, Nalan; Güngör, Sinem; Iscanli, Insa; Er, Berrin; Mendil, Nilgin Alptekinoglu; Usalan, Adnan; Yilmaz, Didem; Keskin, Hülya; Dönmez, Gül Erdal; Yilmaz, Baris; Kargin, Feyza; Saraçoglu, Kemal Tolga; Temel, Sahin; Dal, Hayriye Cankar; Turan, Sema; Talan, Leyla; Hosgün, Derya; Aydemir, Semih; Sungurtekin, Hülya.
Afiliación
  • Tunçay E; Department of Intensive Care, University of Medical Sciences Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey.
  • Moçin Ö; Department of Intensive Care, Health Sciences University Süreyyapasa Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, Istanbul, Turkey.
  • Edibogdu Ö; Department of Intensive Care, Health Sciences University Dr. Suat Seren Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, Istanbul, Turkey.
  • Adigüzel N; Department of Intensive Care, Health Sciences University Süreyyapasa Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, Istanbul, Turkey.
  • Güngör S; Department of Intensive Care, Health Sciences University Süreyyapasa Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, Istanbul, Turkey.
  • Iscanli I; Department of Intensive Care, Health Sciences University Sultan Abdülhamid Han Training and Research Hospital, Istanbul, Turkey.
  • Er B; Department of Intensive Care, TC Ministry of Health, Ankara City Hospital, Ankara, Turkey.
  • Mendil NA; Department of Intensive Care, TC Ministry of Health, Mersin City Hospital, Mersin, Turkey.
  • Usalan A; Department of Intensive Care, Tarsus Medikalpark Hospital, Mersin, Turkey.
  • Yilmaz D; Department of Intensive Care, Tarsus Medikalpark Hospital, Mersin, Turkey.
  • Keskin H; Department of Intensive Care, Health Sciences University Kartal Dr. Lütfi Kirdar City Hospital, Istanbul, Turkey.
  • Dönmez GE; Department of Intensive Care, Health Sciences University Süreyyapasa Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, Istanbul, Turkey.
  • Yilmaz B; Department of Intensive Care, Health Sciences University Süreyyapasa Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, Istanbul, Turkey.
  • Kargin F; Department of Intensive Care, Health Sciences University Kartal Dr. Lütfi Kirdar City Hospital, Istanbul, Turkey.
  • Saraçoglu KT; Department of Intensive Care, Health Sciences University Kartal Dr. Lütfi Kirdar City Hospital, Istanbul, Turkey.
  • Temel S; Department of Intensive Care, Erciyes University Faculty of Medicine, Kayseri, Turkey.
  • Dal HC; Department of Intensive Care, TC Ministry of Health, Ankara City Hospital, Ankara, Turkey.
  • Turan S; Department of Intensive Care, TC Ministry of Health, Ankara City Hospital, Ankara, Turkey.
  • Talan L; Department of Intensive Care, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Hosgün D; Department of Intensive Care, Health Sciences University Ankara Atatürk Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, Ankara, Turkey.
  • Aydemir S; Department of Intensive Care, Health Sciences University Ankara Atatürk Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, Ankara, Turkey.
  • Sungurtekin H; Department of Intensive Care, Pamukkale University Faculty of Medicine, Denizli, Turkey.
Thorac Res Pract ; 25(4): 162-167, 2024 Jul.
Article en En | MEDLINE | ID: mdl-39128056
ABSTRACT

OBJECTIVE:

 Coronavirus disease 2019 (COVID-19) caused morbidity and mortality worldwide. Besides the acute effects, subacute and long-term effects are defined as long-COVID causing morbidity. The intensive care unit (ICU) data of long-COVID-19 cases were evaluated with the participation of 11 centers. MATERIAL AND

METHODS:

 Study was designed by Turkish Thoracic Society Respiratory Failure and Intensive Care Working Group to evaluate long COVID-19 patients. All patients followed up in the ICU with long-COVID diagnosis were included in point prevelance study.

RESULTS:

 A total of 41 long COVID-19 patients from 11 centers were included in the study. Half of the patients were male, mean age was 66 ± 14, body mass index was 27 ± 5. Hypertension, diabetes mellitus, lung cancer, malignancy, and heart failure rates were 27%, 51%, 34%, 34%, and 27%, respectively. Eighty percent had received COVID vaccine. Patients had moderate hypoxemic respiratory failure. APACHE II, SOFA score was 18 (14-26), 6 (3-8), respectively. Forty-six percent received invasive mechanical ventilator support, 42% were sepsis, 17% were septic shock. Bilateral (67%), interstitial involvement (37%) were most common in chest x-ray. Fibrosis (27%) was detected in thorax tomography. Seventy-one percent of patients received antibiotherapy (42% carbapenem, 22% linezolid). Sixty-one percent of the patients received corticosteroid treatment.

CONCLUSION:

 More than half of the patients had pneumonia and the majority of them used broad-spectrum antibiotics. Presence of comorbidities and malignancies, intensive care severity scores, intubation, and sepsis rates were high. Receiving corticosteroid treatment and extensive bilateral radiologic involvement due to COVID-19 might be the reasons for the high re-admission rate for the ICUs.
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Thorac Res Pract Año: 2024 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Thorac Res Pract Año: 2024 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía